BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7944302)

  • 1. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren.
    Cordes M; Snow BJ; Cooper S; Schulzer M; Pate BD; Ruth TJ; Calne DB
    Ann Neurol; 1994 Oct; 36(4):667-70. PubMed ID: 7944302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigrostriatal function in humans studied with positron emission tomography.
    Martin WR; Palmer MR; Patlak CS; Calne DB
    Ann Neurol; 1989 Oct; 26(4):535-42. PubMed ID: 2510586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
    Snow BJ; Bhatt M; Martin WR; Li D; Calne DB
    J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):12-7. PubMed ID: 1901347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
    Cordes M; Poewe W
    Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices.
    Pate BD; Kawamata T; Yamada T; McGeer EG; Hewitt KA; Snow BJ; Ruth TJ; Calne DB
    Ann Neurol; 1993 Sep; 34(3):331-8. PubMed ID: 8363350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal 18F-dopa uptake: absence of an aging effect.
    Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
    J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies?
    Kish SJ; Zhong XH; Hornykiewicz O; Haycock JW
    Ann Neurol; 1995 Aug; 38(2):260-4. PubMed ID: 7654075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET studies of the striatal dopaminergic system in Parkinson's disease (PD).
    Piccini P; Turjanski N; Brooks DJ
    J Neural Transm Suppl; 1995; 45():123-31. PubMed ID: 8748617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studies.
    Dexter DT; Brooks DJ; Harding AE; Burn DJ; Muller DP; Goss-Sampson MA; Jenner PG; Marsden CD
    Ann Neurol; 1994 Mar; 35(3):298-303. PubMed ID: 8122882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.
    Vingerhoets FJ; Snow BJ; Tetrud JW; Langston JW; Schulzer M; Calne DB
    Ann Neurol; 1994 Nov; 36(5):765-70. PubMed ID: 7979223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.
    Takahashi H; Snow BJ; Bhatt MH; Peppard R; Eisen A; Calne DB
    Lancet; 1993 Oct; 342(8878):1016-8. PubMed ID: 8105264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.
    Tai YF; Hoshi R; Brignell CM; Cohen L; Brooks DJ; Curran HV; Piccini P
    Neuropsychopharmacology; 2011 Mar; 36(4):735-43. PubMed ID: 21160467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects.
    Vingerhoets FJ; Snow BJ; Schulzer M; Morrison S; Ruth TJ; Holden JE; Cooper S; Calne DB
    J Nucl Med; 1994 Jan; 35(1):18-24. PubMed ID: 8285951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal function in normal aging: implications for Parkinson's disease.
    Sawle GV; Colebatch JG; Shah A; Brooks DJ; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Dec; 28(6):799-804. PubMed ID: 2126684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Striatal 18F-dopa uptake measuring nigrostriatal function].
    Otsuka M; Masuda K; Kato M
    Nihon Rinsho; 1991 Jul; 49(7):1532-6. PubMed ID: 1909388
    [No Abstract]   [Full Text] [Related]  

  • 16. Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
    Snow BJ; Tooyama I; McGeer EG; Yamada T; Calne DB; Takahashi H; Kimura H
    Ann Neurol; 1993 Sep; 34(3):324-30. PubMed ID: 8363349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in the human nigrostriatal dopaminergic system.
    De Keyser J; Ebinger G; Vauquelin G
    Ann Neurol; 1990 Feb; 27(2):157-61. PubMed ID: 2107785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies.
    Hu XS; Okamura N; Arai H; Higuchi M; Matsui T; Tashiro M; Shinkawa M; Itoh M; Ido T; Sasaki H
    Neurology; 2000 Nov; 55(10):1575-7. PubMed ID: 11094120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study.
    McGowan S; Lawrence AD; Sales T; Quested D; Grasby P
    Arch Gen Psychiatry; 2004 Feb; 61(2):134-42. PubMed ID: 14757589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis.
    Ruottinen HM; Rinne JO; Haaparanta M; Solin O; Bergman J; Oikonen VJ; Järvelä I; Santavuori P
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):622-5. PubMed ID: 9219750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.